New Version of Sanofi Sleeping Pill Faces Delay (Reuters)


Reuters - Sanofi-Aventis SA faces a delay in
launching Ambien CR -- a new form of its best-selling sleeping
pill -- after getting an approvable letter, rather than full
approval, from U.S. regulators.

Read more...